Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Emine Dogan, Ozkan Sever, Burcin Köklü Çakır & Erkan Celik. (2018) Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion. Clinical Ophthalmology 12, pages 1465-1470.
Read now
Read now
Bora Yuksel, Omer Karti, Ozan Celik, Suleyman Gokhan Kerci & Tuncay Kusbeci. (2018) Low frequency ranibizumab versus dexamethasone implant for macular oedema secondary to branch retinal vein occlusion. Clinical and Experimental Optometry 101:1, pages 116-122.
Read now
Read now
Michael W Stewart. (2014) Review of the latest treatments for retinal vein occlusions: emphasis on pharmacologic therapy. Expert Review of Ophthalmology 9:5, pages 361-374.
Read now
Read now
Derek Macdonald. (2014) The ABCs of RVO: A review of retinal venous occlusion. Clinical and Experimental Optometry 97:4, pages 311-323.
Read now
Read now
Articles from other publishers (7)
Nikhil S. Patil, Andrew Mihalache, Arjan S. Dhoot, Marko M. Popovic, Rajeev H. Muni & Peter J. Kertes. (2023) The Impact of Residual Retinal Fluid Following Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Systematic Review. Ophthalmic Surgery, Lasers and Imaging Retina 54:1, pages 50-58.
Crossref
Crossref
Ozlem Eski Yucel, Hakki Birinci & Yuksel Sullu. (2018) The short-term efficacy of intravitreal ranibizumab, aflibercept and dexamethasone implant in the treatment of macular edema due to non-ischemic central retinal vein occlusion. International Ophthalmology 39:4, pages 891-901.
Crossref
Crossref
Jose Garcia-Arumi, Francisco Gómez-Ulla, Navea Amparo, Enrique Cervera, Alex Fonollosa, Luis Arias, Javier Araiz, Juan Donate, Marta Suárez de Figueroa, Lucia Manzanas, Jaume Crespí & Roberto Gallego. (2018) Efficacy and Safety of an Aflibercept Treat-and-Extend Regimen in Treatment-Naïve Patients with Macular Oedema Secondary to Central Retinal Vein Occlusion (CRVO): A Prospective 12-Month, Single-Arm, Multicentre Trial. Journal of Ophthalmology 2018, pages 1-7.
Crossref
Crossref
Donghyoun Noh, Gahyung Ryu, Junyeop Lee & Min Sagong. (2018) Impact of Early Anatomical and Functional Responses to Bevacizumab in Macular Edema Secondary to Branch Retinal Vein Occlusion. Ophthalmologica 239:4, pages 194-204.
Crossref
Crossref
Sebastian M. Waldstein, Alessio Montuoro, Dominika Podkowinski, Ana-Maria Philip, Bianca S. Gerendas, Hrvoje Bogunovic & Ursula Schmidt-Erfurth. (2017) Evaluating the impact of vitreomacular adhesion on anti-VEGF therapy for retinal vein occlusion using machine learning. Scientific Reports 7:1.
Crossref
Crossref
Christophe Chiquet, Alain M. Bron, Morgane Straub, Caroline Dupuy, Rodica Isaico, Florent Aptel & Catherine Creuzot-Garcher. (2016) Retinal Vein Occlusions: Therapeutic Switch in Macular Oedema Treatment with a 12-Month Follow-Up. Ophthalmic Research 55:3, pages 152-158.
Crossref
Crossref
Marcel N. Menke, Andreas Ebneter, Martin S. Zinkernagel & Sebastian Wolf. (2016) Differentiation between Good and Low-Responders to Intravitreal Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusion. Journal of Ophthalmology 2016, pages 1-6.
Crossref
Crossref